“Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer”. Journal of Cancer Research Updates, vol. 11, Oct. 2022, pp. 63-69, https://doi.org/10.30683/1929-2279.2022.11.09.